EBO vs PAR

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

EBO

EBOS FPO NZ [EBO]

49LOW

PAR

PARA BIO FPO [PAR]

49LOW

Score Breakdown

EBO PAR
Technical
71
68
Catalyst
67
67
Sentiment
50
50
Fundamental
100
48
Momentum
39
52
Risk Gate
50
50

Key Metrics

EBO Metric PAR
$3.8BMarket Cap$113.5M
256KAvg Volume (20d)910K
+0.6%Short Interest+0.4%
$38.23052-Week High$0.480
$17.78052-Week Low$0.240
+4.1%Daily Change+2.8%
$18.780Entry Price$0.257
+9.0%ROE-180.2%
+1.8%Profit MarginN/A

Active Signals

EBO Signals

●MACD momentum is picking up steam
●Volume surging at 4.6x normal while price climbs — real buying conviction behind this move
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.3x)
●Moderate revenue growth (+13%)
●Piotroski F-Score strong (8/9, low-confidence approx)

PAR Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Very high P/S ratio (13426.2x)
●Strong revenue growth (+51%)

Ask Scout AI to compare EBO and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EBO Full Analysis → PAR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).